aluates Reports

$ 0.0

Global Nasal Spray Flu Vaccines Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-20R9454

Global Nasal Spray Flu Vaccines Market Insights and Forecast to 2028

BUY CHAPTERS

Global Nasal Spray Flu Vaccines Market Insights, Forecast to 2030

Code: QYRE-Auto-20R9454

Report

December 2024

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Serum Institute of India

Nasal Spray Flu Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nasal Spray Flu Vaccines Market

The global Nasal Spray Flu Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Nasal Spray Flu Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Nasal Spray Flu Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nasal Spray Flu Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nasal Spray Flu Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Nasal Spray Flu Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Nasal Spray Flu Vaccines sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Nasal Spray Flu Vaccines Market Report

Report Metric	Details
Report Name	Nasal Spray Flu Vaccines Market
CAGR	5%
Segment by Type	Trivalent Flu Vaccine Quadrivalent Flu Vaccine
Segment by Application	Hospital Clinic Public Health Agency Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL, Abbott, GlaxoSmithKline, Serum Institute of India
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nasal Spray Flu Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nasal Spray Flu Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nasal Spray Flu Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nasal Spray Flu Vaccines Market report?

Ans: The main players in the Nasal Spray Flu Vaccines Market are CSL, Abbott, GlaxoSmithKline, Serum Institute of India

What are the Application segmentation covered in the Nasal Spray Flu Vaccines Market report?

Ans: The Applications covered in the Nasal Spray Flu Vaccines Market report are Hospital, Clinic, Public Health Agency, Other

What are the Type segmentation covered in the Nasal Spray Flu Vaccines Market report?

Ans: The Types covered in the Nasal Spray Flu Vaccines Market report are Trivalent Flu Vaccine, Quadrivalent Flu Vaccine

1 Study Coverage

1.1 Nasal Spray Flu Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Nasal Spray Flu Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Trivalent Flu Vaccine

1.2.3 Quadrivalent Flu Vaccine

1.3 Market by Application

1.3.1 Global Nasal Spray Flu Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Public Health Agency

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Nasal Spray Flu Vaccines Sales Estimates and Forecasts 2019-2030

2.2 Global Nasal Spray Flu Vaccines Revenue by Region

2.2.1 Global Nasal Spray Flu Vaccines Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Nasal Spray Flu Vaccines Revenue by Region (2019-2024)

2.2.3 Global Nasal Spray Flu Vaccines Revenue by Region (2025-2030)

2.2.4 Global Nasal Spray Flu Vaccines Revenue Market Share by Region (2019-2030)

2.3 Global Nasal Spray Flu Vaccines Sales Estimates and Forecasts 2019-2030

2.4 Global Nasal Spray Flu Vaccines Sales by Region

2.4.1 Global Nasal Spray Flu Vaccines Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Nasal Spray Flu Vaccines Sales by Region (2019-2024)

2.4.3 Global Nasal Spray Flu Vaccines Sales by Region (2025-2030)

2.4.4 Global Nasal Spray Flu Vaccines Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Nasal Spray Flu Vaccines Sales by Manufacturers

3.1.1 Global Nasal Spray Flu Vaccines Sales by Manufacturers (2019-2024)

3.1.2 Global Nasal Spray Flu Vaccines Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nasal Spray Flu Vaccines in 2023

3.2 Global Nasal Spray Flu Vaccines Revenue by Manufacturers

3.2.1 Global Nasal Spray Flu Vaccines Revenue by Manufacturers (2019-2024)

3.2.2 Global Nasal Spray Flu Vaccines Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Nasal Spray Flu Vaccines Revenue in 2023

3.3 Global Key Players of Nasal Spray Flu Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Nasal Spray Flu Vaccines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Nasal Spray Flu Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Nasal Spray Flu Vaccines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Nasal Spray Flu Vaccines, Product Offered and Application

3.8 Global Key Manufacturers of Nasal Spray Flu Vaccines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Nasal Spray Flu Vaccines Sales by Type

4.1.1 Global Nasal Spray Flu Vaccines Historical Sales by Type (2019-2024)

4.1.2 Global Nasal Spray Flu Vaccines Forecasted Sales by Type (2025-2030)

4.1.3 Global Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Nasal Spray Flu Vaccines Revenue by Type

4.2.1 Global Nasal Spray Flu Vaccines Historical Revenue by Type (2019-2024)

4.2.2 Global Nasal Spray Flu Vaccines Forecasted Revenue by Type (2025-2030)

4.2.3 Global Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Nasal Spray Flu Vaccines Price by Type

4.3.1 Global Nasal Spray Flu Vaccines Price by Type (2019-2024)

4.3.2 Global Nasal Spray Flu Vaccines Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Nasal Spray Flu Vaccines Sales by Application

5.1.1 Global Nasal Spray Flu Vaccines Historical Sales by Application (2019-2024)

5.1.2 Global Nasal Spray Flu Vaccines Forecasted Sales by Application (2025-2030)

5.1.3 Global Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Nasal Spray Flu Vaccines Revenue by Application

5.2.1 Global Nasal Spray Flu Vaccines Historical Revenue by Application (2019-2024)

5.2.2 Global Nasal Spray Flu Vaccines Forecasted Revenue by Application (2025-2030)

5.2.3 Global Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Nasal Spray Flu Vaccines Price by Application

5.3.1 Global Nasal Spray Flu Vaccines Price by Application (2019-2024)

5.3.2 Global Nasal Spray Flu Vaccines Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Nasal Spray Flu Vaccines Market Size by Type

6.1.1 US & Canada Nasal Spray Flu Vaccines Sales by Type (2019-2030)

6.1.2 US & Canada Nasal Spray Flu Vaccines Revenue by Type (2019-2030)

6.2 US & Canada Nasal Spray Flu Vaccines Market Size by Application

6.2.1 US & Canada Nasal Spray Flu Vaccines Sales by Application (2019-2030)

6.2.2 US & Canada Nasal Spray Flu Vaccines Revenue by Application (2019-2030)

6.3 US & Canada Nasal Spray Flu Vaccines Market Size by Country

6.3.1 US & Canada Nasal Spray Flu Vaccines Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Nasal Spray Flu Vaccines Sales by Country (2019-2030)

6.3.3 US & Canada Nasal Spray Flu Vaccines Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Nasal Spray Flu Vaccines Market Size by Type

7.1.1 Europe Nasal Spray Flu Vaccines Sales by Type (2019-2030)

7.1.2 Europe Nasal Spray Flu Vaccines Revenue by Type (2019-2030)

7.2 Europe Nasal Spray Flu Vaccines Market Size by Application

7.2.1 Europe Nasal Spray Flu Vaccines Sales by Application (2019-2030)

7.2.2 Europe Nasal Spray Flu Vaccines Revenue by Application (2019-2030)

7.3 Europe Nasal Spray Flu Vaccines Market Size by Country

7.3.1 Europe Nasal Spray Flu Vaccines Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Nasal Spray Flu Vaccines Sales by Country (2019-2030)

7.3.3 Europe Nasal Spray Flu Vaccines Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Nasal Spray Flu Vaccines Market Size

8.1.1 China Nasal Spray Flu Vaccines Sales (2019-2030)

8.1.2 China Nasal Spray Flu Vaccines Revenue (2019-2030)

8.2 China Nasal Spray Flu Vaccines Market Size by Application

8.2.1 China Nasal Spray Flu Vaccines Sales by Application (2019-2030)

8.2.2 China Nasal Spray Flu Vaccines Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Nasal Spray Flu Vaccines Market Size by Type

9.1.1 Asia Nasal Spray Flu Vaccines Sales by Type (2019-2030)

9.1.2 Asia Nasal Spray Flu Vaccines Revenue by Type (2019-2030)

9.2 Asia Nasal Spray Flu Vaccines Market Size by Application

9.2.1 Asia Nasal Spray Flu Vaccines Sales by Application (2019-2030)

9.2.2 Asia Nasal Spray Flu Vaccines Revenue by Application (2019-2030)

9.3 Asia Nasal Spray Flu Vaccines Sales by Region

9.3.1 Asia Nasal Spray Flu Vaccines Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Nasal Spray Flu Vaccines Revenue by Region (2019-2030)

9.3.3 Asia Nasal Spray Flu Vaccines Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Market Size by Type

10.1.1 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Market Size by Application

10.2.1 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Country

10.3.1 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sanofi Pasteur

11.1.1 Sanofi Pasteur Company Information

11.1.2 Sanofi Pasteur Overview

11.1.3 Sanofi Pasteur Nasal Spray Flu Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sanofi Pasteur Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Pasteur Recent Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Information

11.2.2 AstraZeneca Overview

11.2.3 AstraZeneca Nasal Spray Flu Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 AstraZeneca Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AstraZeneca Recent Developments

11.3 CSL

11.3.1 CSL Company Information

11.3.2 CSL Overview

11.3.3 CSL Nasal Spray Flu Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 CSL Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 CSL Recent Developments

11.4 Abbott

11.4.1 Abbott Company Information

11.4.2 Abbott Overview

11.4.3 Abbott Nasal Spray Flu Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Abbott Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Abbott Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Information

11.5.2 GlaxoSmithKline Overview

11.5.3 GlaxoSmithKline Nasal Spray Flu Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 GlaxoSmithKline Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 GlaxoSmithKline Recent Developments

11.6 Serum Institute of India

11.6.1 Serum Institute of India Company Information

11.6.2 Serum Institute of India Overview

11.6.3 Serum Institute of India Nasal Spray Flu Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Serum Institute of India Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Serum Institute of India Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Nasal Spray Flu Vaccines Industry Chain Analysis

12.2 Nasal Spray Flu Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Nasal Spray Flu Vaccines Production Mode & Process

12.4 Nasal Spray Flu Vaccines Sales and Marketing

12.4.1 Nasal Spray Flu Vaccines Sales Channels

12.4.2 Nasal Spray Flu Vaccines Distributors

12.5 Nasal Spray Flu Vaccines Customers

13 Market Dynamics

13.1 Nasal Spray Flu Vaccines Industry Trends

13.2 Nasal Spray Flu Vaccines Market Drivers

13.3 Nasal Spray Flu Vaccines Market Challenges

13.4 Nasal Spray Flu Vaccines Market Restraints

14 Key Findings in The Global Nasal Spray Flu Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Serum Institute of India

List of Tables

Table 1. Global Nasal Spray Flu Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Trivalent Flu Vaccine

Table 3. Major Manufacturers of Quadrivalent Flu Vaccine

Table 4. Global Nasal Spray Flu Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Nasal Spray Flu Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Nasal Spray Flu Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Nasal Spray Flu Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Nasal Spray Flu Vaccines Revenue Market Share by Region (2019-2024)

Table 9. Global Nasal Spray Flu Vaccines Revenue Market Share by Region (2025-2030)

Table 10. Global Nasal Spray Flu Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Nasal Spray Flu Vaccines Sales by Region (2019-2024) & (K Doses)

Table 12. Global Nasal Spray Flu Vaccines Sales by Region (2025-2030) & (K Doses)

Table 13. Global Nasal Spray Flu Vaccines Sales Market Share by Region (2019-2024)

Table 14. Global Nasal Spray Flu Vaccines Sales Market Share by Region (2025-2030)

Table 15. Global Nasal Spray Flu Vaccines Sales by Manufacturers (2019-2024) & (K Doses)

Table 16. Global Nasal Spray Flu Vaccines Sales Share by Manufacturers (2019-2024)

Table 17. Global Nasal Spray Flu Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Nasal Spray Flu Vaccines Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Nasal Spray Flu Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Nasal Spray Flu Vaccines Price by Manufacturers 2019-2024 (USD/Dose)

Table 21. Global Nasal Spray Flu Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Nasal Spray Flu Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Flu Vaccines as of 2023)

Table 23. Global Key Manufacturers of Nasal Spray Flu Vaccines, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Nasal Spray Flu Vaccines, Product Offered and Application

Table 25. Global Key Manufacturers of Nasal Spray Flu Vaccines, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Nasal Spray Flu Vaccines Sales by Type (2019-2024) & (K Doses)

Table 28. Global Nasal Spray Flu Vaccines Sales by Type (2025-2030) & (K Doses)

Table 29. Global Nasal Spray Flu Vaccines Sales Share by Type (2019-2024)

Table 30. Global Nasal Spray Flu Vaccines Sales Share by Type (2025-2030)

Table 31. Global Nasal Spray Flu Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Nasal Spray Flu Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Nasal Spray Flu Vaccines Revenue Share by Type (2019-2024)

Table 34. Global Nasal Spray Flu Vaccines Revenue Share by Type (2025-2030)

Table 35. Nasal Spray Flu Vaccines Price by Type (2019-2024) & (USD/Dose)

Table 36. Global Nasal Spray Flu Vaccines Price Forecast by Type (2025-2030) & (USD/Dose)

Table 37. Global Nasal Spray Flu Vaccines Sales by Application (2019-2024) & (K Doses)

Table 38. Global Nasal Spray Flu Vaccines Sales by Application (2025-2030) & (K Doses)

Table 39. Global Nasal Spray Flu Vaccines Sales Share by Application (2019-2024)

Table 40. Global Nasal Spray Flu Vaccines Sales Share by Application (2025-2030)

Table 41. Global Nasal Spray Flu Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Nasal Spray Flu Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Nasal Spray Flu Vaccines Revenue Share by Application (2019-2024)

Table 44. Global Nasal Spray Flu Vaccines Revenue Share by Application (2025-2030)

Table 45. Nasal Spray Flu Vaccines Price by Application (2019-2024) & (USD/Dose)

Table 46. Global Nasal Spray Flu Vaccines Price Forecast by Application (2025-2030) & (USD/Dose)

Table 47. US & Canada Nasal Spray Flu Vaccines Sales by Type (2019-2024) & (K Doses)

Table 48. US & Canada Nasal Spray Flu Vaccines Sales by Type (2025-2030) & (K Doses)

Table 49. US & Canada Nasal Spray Flu Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Nasal Spray Flu Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Nasal Spray Flu Vaccines Sales by Application (2019-2024) & (K Doses)

Table 52. US & Canada Nasal Spray Flu Vaccines Sales by Application (2025-2030) & (K Doses)

Table 53. US & Canada Nasal Spray Flu Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Nasal Spray Flu Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Nasal Spray Flu Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Nasal Spray Flu Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Nasal Spray Flu Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Nasal Spray Flu Vaccines Sales by Country (2019-2024) & (K Doses)

Table 59. US & Canada Nasal Spray Flu Vaccines Sales by Country (2025-2030) & (K Doses)

Table 60. Europe Nasal Spray Flu Vaccines Sales by Type (2019-2024) & (K Doses)

Table 61. Europe Nasal Spray Flu Vaccines Sales by Type (2025-2030) & (K Doses)

Table 62. Europe Nasal Spray Flu Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Nasal Spray Flu Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Nasal Spray Flu Vaccines Sales by Application (2019-2024) & (K Doses)

Table 65. Europe Nasal Spray Flu Vaccines Sales by Application (2025-2030) & (K Doses)

Table 66. Europe Nasal Spray Flu Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Nasal Spray Flu Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Nasal Spray Flu Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Nasal Spray Flu Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Nasal Spray Flu Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Nasal Spray Flu Vaccines Sales by Country (2019-2024) & (K Doses)

Table 72. Europe Nasal Spray Flu Vaccines Sales by Country (2025-2030) & (K Doses)

Table 73. China Nasal Spray Flu Vaccines Sales by Type (2019-2024) & (K Doses)

Table 74. China Nasal Spray Flu Vaccines Sales by Type (2025-2030) & (K Doses)

Table 75. China Nasal Spray Flu Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Nasal Spray Flu Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Nasal Spray Flu Vaccines Sales by Application (2019-2024) & (K Doses)

Table 78. China Nasal Spray Flu Vaccines Sales by Application (2025-2030) & (K Doses)

Table 79. China Nasal Spray Flu Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Nasal Spray Flu Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Nasal Spray Flu Vaccines Sales by Type (2019-2024) & (K Doses)

Table 82. Asia Nasal Spray Flu Vaccines Sales by Type (2025-2030) & (K Doses)

Table 83. Asia Nasal Spray Flu Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Nasal Spray Flu Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Nasal Spray Flu Vaccines Sales by Application (2019-2024) & (K Doses)

Table 86. Asia Nasal Spray Flu Vaccines Sales by Application (2025-2030) & (K Doses)

Table 87. Asia Nasal Spray Flu Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Nasal Spray Flu Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Nasal Spray Flu Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Nasal Spray Flu Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Nasal Spray Flu Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Nasal Spray Flu Vaccines Sales by Region (2019-2024) & (K Doses)

Table 93. Asia Nasal Spray Flu Vaccines Sales by Region (2025-2030) & (K Doses)

Table 94. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Type (2019-2024) & (K Doses)

Table 95. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Type (2025-2030) & (K Doses)

Table 96. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Application (2019-2024) & (K Doses)

Table 99. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Application (2025-2030) & (K Doses)

Table 100. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Country (2019-2024) & (K Doses)

Table 106. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales by Country (2025-2030) & (K Doses)

Table 107. Sanofi Pasteur Company Information

Table 108. Sanofi Pasteur Description and Major Businesses

Table 109. Sanofi Pasteur Nasal Spray Flu Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 110. Sanofi Pasteur Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Sanofi Pasteur Recent Developments

Table 112. AstraZeneca Company Information

Table 113. AstraZeneca Description and Major Businesses

Table 114. AstraZeneca Nasal Spray Flu Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 115. AstraZeneca Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. AstraZeneca Recent Developments

Table 117. CSL Company Information

Table 118. CSL Description and Major Businesses

Table 119. CSL Nasal Spray Flu Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 120. CSL Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. CSL Recent Developments

Table 122. Abbott Company Information

Table 123. Abbott Description and Major Businesses

Table 124. Abbott Nasal Spray Flu Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 125. Abbott Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Abbott Recent Developments

Table 127. GlaxoSmithKline Company Information

Table 128. GlaxoSmithKline Description and Major Businesses

Table 129. GlaxoSmithKline Nasal Spray Flu Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 130. GlaxoSmithKline Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. GlaxoSmithKline Recent Developments

Table 132. Serum Institute of India Company Information

Table 133. Serum Institute of India Description and Major Businesses

Table 134. Serum Institute of India Nasal Spray Flu Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 135. Serum Institute of India Nasal Spray Flu Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Serum Institute of India Recent Developments

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Nasal Spray Flu Vaccines Distributors List

Table 140. Nasal Spray Flu Vaccines Customers List

Table 141. Nasal Spray Flu Vaccines Market Trends

Table 142. Nasal Spray Flu Vaccines Market Drivers

Table 143. Nasal Spray Flu Vaccines Market Challenges

Table 144. Nasal Spray Flu Vaccines Market Restraints

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Nasal Spray Flu Vaccines Product Picture

Figure 2. Global Nasal Spray Flu Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Nasal Spray Flu Vaccines Market Share by Type in 2023 & 2030

Figure 4. Trivalent Flu Vaccine Product Picture

Figure 5. Quadrivalent Flu Vaccine Product Picture

Figure 6. Global Nasal Spray Flu Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Nasal Spray Flu Vaccines Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Public Health Agency

Figure 11. Other

Figure 12. Nasal Spray Flu Vaccines Report Years Considered

Figure 13. Global Nasal Spray Flu Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Nasal Spray Flu Vaccines Revenue 2019-2030 (US$ Million)

Figure 15. Global Nasal Spray Flu Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Nasal Spray Flu Vaccines Revenue Market Share by Region (2019-2030)

Figure 17. Global Nasal Spray Flu Vaccines Sales 2019-2030 ((K Doses)

Figure 18. Global Nasal Spray Flu Vaccines Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Nasal Spray Flu Vaccines Sales YoY (2019-2030) & (K Doses)

Figure 20. US & Canada Nasal Spray Flu Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Nasal Spray Flu Vaccines Sales YoY (2019-2030) & (K Doses)

Figure 22. Europe Nasal Spray Flu Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Nasal Spray Flu Vaccines Sales YoY (2019-2030) & (K Doses)

Figure 24. China Nasal Spray Flu Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Nasal Spray Flu Vaccines Sales YoY (2019-2030) & (K Doses)

Figure 26. Asia (excluding China) Nasal Spray Flu Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales YoY (2019-2030) & (K Doses)

Figure 28. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Nasal Spray Flu Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Nasal Spray Flu Vaccines in the World: Market Share by Nasal Spray Flu Vaccines Revenue in 2023

Figure 31. Global Nasal Spray Flu Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

Figure 33. Global Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

Figure 34. Global Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

Figure 35. Global Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Nasal Spray Flu Vaccines Revenue Share by Country (2019-2030)

Figure 41. US & Canada Nasal Spray Flu Vaccines Sales Share by Country (2019-2030)

Figure 42. U.S. Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

Figure 45. Europe Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

Figure 46. Europe Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

Figure 47. Europe Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

Figure 48. Europe Nasal Spray Flu Vaccines Revenue Share by Country (2019-2030)

Figure 49. Europe Nasal Spray Flu Vaccines Sales Share by Country (2019-2030)

Figure 50. Germany Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 51. France Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 55. China Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

Figure 56. China Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

Figure 57. China Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

Figure 58. China Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

Figure 59. Asia Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

Figure 60. Asia Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

Figure 61. Asia Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

Figure 62. Asia Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

Figure 63. Asia Nasal Spray Flu Vaccines Revenue Share by Region (2019-2030)

Figure 64. Asia Nasal Spray Flu Vaccines Sales Share by Region (2019-2030)

Figure 65. Japan Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 69. India Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Nasal Spray Flu Vaccines Sales Share by Country (2019-2030)

Figure 76. Brazil Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Nasal Spray Flu Vaccines Revenue (2019-2030) & (US$ Million)

Figure 81. Nasal Spray Flu Vaccines Value Chain

Figure 82. Nasal Spray Flu Vaccines Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions